FDA | What's New
Follow
FDA Approves First Generic of Priftin (rifapentine) Tablets
The U.S. Food and Drug Administration has approved the first generic of Priftin (rifapentine) tablets, a medication for the treatment of active pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis in combination with one or more antituberculosis drugs.
